Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 15, 2013Blood

Three-Year Survival Results From An Ongoing Phase 2 Study Of Brentuximab Vedotin In Patients With Relapsed Or Refractory Systemic Anaplastic Large Cell Lymphoma

View Full Paper
Ask AI
Bookmark
Share

Authors

BPBarbara ProRARanjana H. AdvaniPBPauline Brice

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Pro et al. (2013) studied this question.

synapsesocial.com/papers/6a260bc77fe57b7c5fd40a25https://doi.org/10.1182/blood.v122.21.1809.1809
View Full Paper
Ask AI
Bookmark
Share